Turn Therapeutics reported earnings of -$ 0.21 per TTRX share on Nov 9, 2026, beating analysts' expectations by
| Report Date | Nov 9, 2026 |
|---|---|
| Forecasted EPS | -$ 0.09 |
| Earnings Per Share (Surprise) | -$ 0.21 (-$ 0.12) |
| Last Year's EPS | -$ 0.05 |
| EPS YoY Change |
Out of the last 6 earnings reporting periods, Turn Therapeutics beat analysts’ expectations 1 times and fell short of expectations 4 time(s). Turn Therapeutics reported earnings per share of -$ 0.21 in the last report falling to reach an estimated EPS of -$ 0.09 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 9, 2026 | -$ 0.09 | -$ 0.21 | -$ 0.07 | |
| Aug 13, 2026 | -$ 0.02 | -$ 0.20 | -$ 0.09 | |
| May 11, 2026 | -$ 0.02 | -$ 0.03 | - | - |
| Mar 31, 2026 | -$ 0.05 | $ 0.0095 | - | - |
| Nov 13, 2025 | -$ 0.05 | -$ 0.07 | - | - |
| Sep 2, 2025 | - | -$ 0.09 | - | - |
Turn Therapeutics’s stock was trading at $ 9.48 on Nov 8, 2026 a day before the last earnings report was released.Following the release of the earnings report, TTRX’s price increased to $ 9.92 on Nov 10, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 9, 2026 | -$ 0.21 | $ 9.48 | $ 9.92 | |
| Aug 13, 2026 | -$ 0.20 | $ 10.54 | $ 9.57 | |
| May 11, 2026 | -$ 0.03 | $ 3.79 | $ 3.98 | |
| Mar 31, 2026 | $ 0.0095 | $ 3.22 | $ 3.12 | |
| Nov 13, 2025 | -$ 0.07 | $ 4.40 | $ 4.00 |
Turn Therapeutics released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Turn Therapeutics missed analysts’ expectations during the last earnings period by
